Ming Zhou

Ming Zhou serves as an Assistant Professor in Pharmaceutical Chemistry at the University of Kansas, driving innovation at the biology-materials interface to solve critical healthcare challenges.

His academic journey includes:

• Postdoctoral Associate in Mechanical Engineering at MIT (2023)
• Research Fellow at Brigham and Women’s Hospital, Harvard Medical School (2023)
• Ph.D. in Chemical Engineering from UCLA (2018)
• M.S. in Biochemistry from Zhejiang University (2013)
• B.S. in Bioengineering from Zhengzhou University (2010)

Research focuses on:

• Non-viral CRISPR Delivery: Engineering nanovehicles for precise ribonucleoprotein delivery to correct genetic disorders while minimizing off-target effects.
• GI-Resident Protein Delivery: Developing microdevices for targeted, sustained oral protein release to treat gastrointestinal cancers and metabolic diseases.
• Multianalyte Biosensors: Creating high-resolution microelectrode arrays for real-time in vivo monitoring of multiple biochemicals through advanced biomolecule patterning.

His work bridges nanotechnology, gene editing, and biomedical engineering to transform therapeutic delivery and diagnostic capabilities.